Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Current Opinion in Pharmacology
|
November 3, 2007
Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases
Brenda J Marsh, Mary P Stenzel-Poore
Current Neuropharmacology
|
March 2, 2010
Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant
Rebecca L Williams-Karnesky, Mary P Stenzel-Poore
Translational Stroke Research
|
March 19, 2013
Steps to translate preconditioning from basic research to the clinic
Frances R Bahjat, Raffaella Gesuete, Mary P Stenzel-Poore
Journal of Neuropathology and Experimental Neurology
|
April 9, 2014
Toll-like receptors and ischemic brain injury
Raffaella Gesuete, Steven G Kohama, Mary P Stenzel-Poore
Acta Neurochirurgica. Supplement
|
October 15, 2015
Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection
Raffaella Gesuete, Susan L Stevens, Mary P Stenzel-Poore
Trends in Cardiovascular Medicine
|
June 19, 2002
Corticotropin-releasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress
Sarah C Coste, Robert F Quintos, Mary P Stenzel-Poore
Future Neurology
|
November 4, 2009
It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection
Philberta Y Leung, Amy Eb Packard, Mary P Stenzel-Poore
Neuropharmacology
|
March 1, 2008
Mechanisms of ischemic brain damage
Kristian P Doyle, Roger P Simon, Mary P Stenzel-Poore
Stroke
|
October 2, 2004
Genomics of preconditioning
Mary P Stenzel-Poore, Susan L Stevens, Roger P Simon
Stroke
|
June 19, 2014
Reprogramming the response to stroke by preconditioning
Susan L Stevens, Keri B Vartanian, Mary P Stenzel-Poore
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Current Opinion in Pharmacology
|
November 3, 2007
Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases
Brenda J Marsh, Mary P Stenzel-Poore
Current Neuropharmacology
|
March 2, 2010
Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant
Rebecca L Williams-Karnesky, Mary P Stenzel-Poore
Translational Stroke Research
|
March 19, 2013
Steps to translate preconditioning from basic research to the clinic
Frances R Bahjat, Raffaella Gesuete, Mary P Stenzel-Poore
Journal of Neuropathology and Experimental Neurology
|
April 9, 2014
Toll-like receptors and ischemic brain injury
Raffaella Gesuete, Steven G Kohama, Mary P Stenzel-Poore
Acta Neurochirurgica. Supplement
|
October 15, 2015
Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection
Raffaella Gesuete, Susan L Stevens, Mary P Stenzel-Poore
Trends in Cardiovascular Medicine
|
June 19, 2002
Corticotropin-releasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress
Sarah C Coste, Robert F Quintos, Mary P Stenzel-Poore
Future Neurology
|
November 4, 2009
It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection
Philberta Y Leung, Amy Eb Packard, Mary P Stenzel-Poore
Neuropharmacology
|
March 1, 2008
Mechanisms of ischemic brain damage
Kristian P Doyle, Roger P Simon, Mary P Stenzel-Poore
Stroke
|
October 2, 2004
Genomics of preconditioning
Mary P Stenzel-Poore, Susan L Stevens, Roger P Simon
Stroke
|
June 19, 2014
Reprogramming the response to stroke by preconditioning
Susan L Stevens, Keri B Vartanian, Mary P Stenzel-Poore
Page
of 6